These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Anti-centromere antibody, biological marker of the CREST syndrome as distinct from scleroderma].
    Author: Rouquette-Gally AM, Stern MH, Prost AC, Abuaf N, Homberg JC, Combrisson A.
    Journal: Presse Med; ; 14(28):1497-500. PubMed ID: 2931679.
    Abstract:
    Using HEp2 cells to study antinuclear antibodies has resulted in the discovery of the anti-centromere antibody which is thought to separate the CREST syndrome from progressive systemic sclerosis (scleroderma). This antibody seems to be exceptional in healthy subjects and are in patients with connective tissue diseases, except for scleroderma. It has also been found in CREST syndrome associated with other diseases, such as primary cirrhosis and neoplasias. In our study, the sensitivity of the anti-centromere antibody was 89.1% and its specificity 92.3% which shows that it is worth looking for.
    [Abstract] [Full Text] [Related] [New Search]